5-Hydrazinyl-2-methoxypyridine hydrochloride

Catalog No.: 
ACDIPS825
CAS No.: 
179543-88-5
Molecular Formula: 
C6H10ClN3O
Molecular Weight: 
175.62
5-Hydrazinyl-2-methoxypyridine hydrochloride structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
5g97%$105.00In stockIn stock
25g97%$509.00In stockIn stock
100g97%$1558.00InquiryInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Name5-Hydrazinyl-2-methoxypyridine hydrochloride
IUPAC Name5-Hydrazinyl-2-methoxypyridine hydrochloride
MDL No.MFCD23701461
Molecular FormulaC6H10ClN3O
Molecular Weight175.62
SMILESCOC1=NC=C(NN)C=C1.[H]Cl
InChI KeyGNBNHMWUFAOTLY-UHFFFAOYSA-N
Synonym5-Hydrazinyl-2-methoxypyridine--hydrogen chloride (1/1) | SCHEMBL2917342 | Pyridine, 5-hydrazino-2-methoxy-, monohydrochloride | DS-4191 | MFCD23701461 | (6-Methoxypyridin-3-yl)hydrazine HCl | FT-0699478 | 5-Hydrazinyl-2-methoxypyridinehydrochloride | 5-H
CAS No.179543-88-5
PubChem CID23090203

Safety Data

Pictogram
Harmful or irritant
Signal Word
Achtung
Hazard Statement(s)
H302-H315-H319-H332-H335
Precautionary Statement(s)
P261-P280-P305+P351+P338

Synthetic Route by SureRoute

1. ACDIPS825 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACCFQG795 route compound structure diagram
    ACCFQG7956628-77-9In Stock
  2. Then
  3. ACDIPS825 route product structure diagram
    ACDIPS825179543-88-5In Stock
Inquiry

2. ACDIPS825 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Then
  3. ACDIPS825 route product structure diagram
    ACDIPS825179543-88-5In Stock
Inquiry

3. ACDIPS825 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Then
  3. ACDIPS825 route product structure diagram
    ACDIPS825179543-88-5In Stock
Inquiry

Comments (0)